Proteome Analyses Reveal Positive Association of COL2A1, MPO, TYMS, and IGFBP5 with Canine Mammary Gland Malignancy
暂无分享,去创建一个
[1] M. W. Yaish,et al. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells , 2018, BMC Cancer.
[2] Zhongming Zhao,et al. Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer. , 2017, Cancer research.
[3] V. Ponomarev,et al. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. , 2017, International journal of oncology.
[4] M. Myers,et al. Biomarkers in Veterinary Medicine. , 2017, Annual review of animal biosciences.
[5] U. Güth,et al. MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity , 2016, BMC Cancer.
[6] Li‐yu Lee,et al. Proteomics Analysis Reveals Involvement of Krt17 in Areca Nut-Induced Oral Carcinogenesis. , 2016, Journal of proteome research.
[7] W. Jones,et al. Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high‐grade serous ovarian cancer , 2016, International journal of cancer.
[8] I. Berindan‐Neagoe,et al. In vitro comparative models for canine and human breast cancers , 2016, Clujul medical.
[9] Kai-Ping Chang,et al. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma , 2015, Proteomics.
[10] Yaritza Salas,et al. Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem , 2015, PloS one.
[11] G. Sauter,et al. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer , 2015, Oncotarget.
[12] Ting Wang,et al. Association between TYMS Expression and Efficacy of Pemetrexed–Based Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis , 2013, PloS one.
[13] P. Cuesta,et al. Prognostic Value of Histological Grading in Noninflammatory Canine Mammary Carcinomas in a Prospective Study With Two-Year Follow-Up , 2013, Veterinary pathology.
[14] G. Heinze,et al. Association of myeloperoxidase with ovarian cancer , 2013, Tumor Biology.
[15] R. Klopfleisch,et al. Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors? , 2011, Journal of proteome research.
[16] V. Zappulli,et al. Development, Anatomy, Histology, Lymphatic Drainage, Clinical Features, and Cell Differentiation Markers of Canine Mammary Gland Neoplasms , 2011, Veterinary pathology.
[17] R. Klopfleisch,et al. Molecular Carcinogenesis of Canine Mammary Tumors , 2011, Veterinary pathology.
[18] V. Zappulli,et al. Classification and Grading of Canine Mammary Tumors , 2011, Veterinary pathology.
[19] R. Klopfleisch,et al. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. , 2010, Journal of proteome research.
[20] K. Uzawa,et al. Down-regulated expression of SERPIN genes located on chromosome 18q21 in oral squamous cell carcinomas. , 2010, Oncology reports.
[21] D. Trinh,et al. Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer. , 2010, Cancer research.
[22] Karl Mechtler,et al. High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all. , 2009, Journal of proteome research.
[23] G. Kristiansen,et al. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation , 2008, Oncogene.
[24] Zheng Wang,et al. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. , 2008, Cancer research.
[25] Arndt Hartmann,et al. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis , 2008, BMC Cancer.
[26] J. Zachary,et al. Pathologic basis of veterinary disease , 2007 .
[28] J. Beattie,et al. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. , 2006, The Biochemical journal.
[29] Chao-Chin Chang,et al. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). , 2005, Journal of the American Veterinary Medical Association.
[30] T. Constantinidis,et al. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. , 2005, Journal of comparative pathology.
[31] Maria Paola Costi,et al. Thymidylate synthase structure, function and implication in drug discovery. , 2005, Current medicinal chemistry.
[32] K. Sorenmo,et al. Canine mammary gland tumors. , 2003, The Veterinary clinics of North America. Small animal practice.